Biscayne Neurotherapeutics Inc., of Miami, completed a $3 million series B financing. The financing was led by the Global Health Sciences Fund of Quark Venture and GF Securities, along with Mesa Verde Venture Partners. Existing Biscayne investors and new private investors also participated.